• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acadia Healthcare Announces Christopher Hunter as New Chief Executive Officer

    4/1/22 8:30:00 AM ET
    $ACHC
    $AFTR
    Medical Specialities
    Health Care
    Blank Checks
    Finance
    Get the next $ACHC alert in real time by email

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that its Board of Directors has named Christopher Hunter as the Company's new Chief Executive Officer. He will join Acadia on April 11, 2022 and will serve on the Company's Board of Directors. Hunter brings an array of executive and healthcare experience from prior senior leadership roles at Humana, TriZetto and BlueCross BlueShield of Tennessee. He replaces Debbie Osteen, who became the Company's Chief Executive Officer in 2018 and oversaw more than three years of successful growth. Osteen has entered into a consulting agreement to assist with the transition and will remain on Acadia's Board of Directors.

    "The Board conducted a thorough and highly selective process to find a Chief Executive Officer who would complement our existing executive team and build on our strong foundation," said Reeve B. Waud, Chairman of Acadia's Board of Directors. "Chris brings the right combination of skills and expertise to lead Acadia as we continue to extend our market reach to meet the behavioral health needs of millions of Americans. His proven track record of leadership and innovative growth within the healthcare industry will ensure that we continue to execute our strategic growth plan with favorable results. At the same time, Chris believes in our objective to remain a patient-first organization focused on quality of care and an employer of choice delivering strong returns for our stockholders over the long term. Chris has the complete confidence of the Board, and we are fortunate to also have the support of a committed executive management team. Together, we look forward to the opportunities ahead for Acadia as we advance our position as a leading behavioral healthcare provider.

    "We greatly appreciate Debbie's important contributions to Acadia's growth and success, and we are confident this will be a smooth transition of leadership. We are pleased to have Debbie remain on the Company's Board as we continue to benefit from her expertise and valuable insight," added Waud.

    Hunter joins Acadia's experienced and proven leadership team, bringing more than 20 years of healthcare experience and expertise across a range of sectors, multiple technology-focused companies, as well as the investment banking industry. Most recently, he served as President of Humana's Group, Military & Specialty Segment, where he oversaw three distinct business units, totaling approximately $7 billion in revenue and serving 20 million members across 45 states. He also served as Humana's Chief Strategy Officer with responsibility for all corporate strategy, merger and acquisitions and partnership activities.

    "This is an incredible honor, and I am excited to join such a strong, respected organization that is addressing a critical societal need at a pivotal time for our country," said Hunter. "With a growing patient base and an industry-leading executive team already in place, I'm looking forward to building on the successful trajectory set by Debbie and the leadership team. I am proud to work with Acadia's committed facility leaders and 22,500 dedicated employees across the country with a shared mission to provide high-quality behavioral healthcare services to existing and new communities."

    Hunter received his bachelor's degree with highest honors from the University of North Carolina at Chapel Hill and an M.B.A. from the Harvard Business School. His recent board experience includes AfterNext HealthTech (NYSE:AFTR), Availity, Youth Villages and the UNC-Chapel Hill Honors Program.

    About Acadia

    Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2021, Acadia operated a network of 238 behavioral healthcare facilities with approximately 10,500 beds in 40 states and Puerto Rico. With more than 22,500 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220331006078/en/

    Get the next $ACHC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHC
    $AFTR

    CompanyDatePrice TargetRatingAnalyst
    Acadia Healthcare Company Inc.
    $ACHC
    1/22/2026$15.00Buy → Hold
    Jefferies
    Acadia Healthcare Company Inc.
    $ACHC
    12/3/2025$14.00Outperform → Market Perform
    Leerink Partners
    Acadia Healthcare Company Inc.
    $ACHC
    12/3/2025$13.00Neutral → Underperform
    BofA Securities
    Acadia Healthcare Company Inc.
    $ACHC
    9/10/2025$25.00Buy → Neutral
    BofA Securities
    Acadia Healthcare Company Inc.
    $ACHC
    8/14/2025$26.00Strong Buy → Outperform
    Raymond James
    Acadia Healthcare Company Inc.
    $ACHC
    2/28/2025$43.00 → $35.00Overweight → Equal Weight
    Barclays
    Acadia Healthcare Company Inc.
    $ACHC
    1/7/2025$70.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Acadia Healthcare Company Inc.
    $ACHC
    12/12/2024$45.00 → $75.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $ACHC
    $AFTR
    SEC Filings

    View All

    Acadia Healthcare Company Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    4/23/26 4:20:51 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.

    SCHEDULE 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    3/26/26 3:05:53 PM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by Acadia Healthcare Company Inc.

    DEFA14A - Acadia Healthcare Company, Inc. (0001520697) (Filer)

    3/25/26 5:03:43 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    $AFTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer

    Reaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int

    4/23/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of the market. Acadia will also conduct a conference call with institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2025, Acadia operated a network of 277 behavioral healthcare fa

    4/8/26 10:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors

    Wade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in

    3/12/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    $AFTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Acadia Healthcare downgraded by Jefferies with a new price target

    Jefferies downgraded Acadia Healthcare from Buy to Hold and set a new price target of $15.00

    1/22/26 8:24:52 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Acadia Healthcare from Outperform to Market Perform and set a new price target of $14.00

    12/3/25 8:27:09 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare downgraded by BofA Securities with a new price target

    BofA Securities downgraded Acadia Healthcare from Neutral to Underperform and set a new price target of $13.00

    12/3/25 8:27:09 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    $AFTR
    Leadership Updates

    Live Leadership Updates

    View All

    Acadia Healthcare Appoints David Duckworth as Interim Chief Financial Officer

    Reaffirms Financial Guidance for First Quarter and Full Year 2026 Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced the appointment of David Duckworth, former Chief Financial Officer of Acadia, as Interim Chief Financial Officer, effective May 1, 2026. Duckworth succeeds Todd Young, who is departing from the Company to pursue a CFO role at a private equity-backed animal health company. Young will remain with the Company through April 30, 2026, and will participate in the Company's first quarter earnings call scheduled for the morning of April 30. Debra K. Osteen, Chief Executive Officer of Acadia, said, "We are pleased to welcome David back as Int

    4/23/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Daniel Cancelmi to Board of Directors

    Wade D. Miquelon to Retire from the Board at Upcoming Annual Meeting Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia") today announced that it has appointed Daniel Cancelmi to its Board of Directors, effective immediately. Mr. Cancelmi is a seasoned finance leader with an expansive knowledge of healthcare and a proven track record of driving superior financial performance. Most recently, he served as Executive Vice President and Chief Financial Officer of Tenet Healthcare Corporation, where he played a significant role in the company's transformation and in strengthening its balance sheet. Over the course of his three-decade career at Tenet, he held a range of finance roles of in

    3/12/26 4:15:00 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Appoints Debbie Osteen as Chief Executive Officer

    Reaffirms Full-Year 2025 Guidance Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced that Debra K. Osteen, former Board member and former Chief Executive Officer of Acadia, has been appointed CEO, effective immediately. Osteen, who has also been appointed as a member of the Board, succeeds Chris Hunter, who is departing the Company and its Board of Directors. Reeve Waud, Chairman of Acadia's Board of Directors, said, "As Acadia continues to take decisive steps to optimize its growth investments and existing portfolio amidst ongoing macro headwinds facing many healthcare providers, the Board believes now is the right time to transition leadership. D

    1/20/26 8:00:00 AM ET
    $ACHC
    $UHS
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    $ACHC
    $AFTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Farley Brian

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    4/13/26 5:01:02 PM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form 4 filed by Young Todd S.

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    4/13/26 5:01:04 PM ET
    $ACHC
    Medical Specialities
    Health Care

    SEC Form 4 filed by Cancelmi Daniel J

    4 - Acadia Healthcare Company, Inc. (0001520697) (Issuer)

    3/18/26 6:18:48 PM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    $AFTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/14/24 1:28:32 PM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/12/24 9:50:14 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Acadia Healthcare Company Inc.

    SC 13G/A - Acadia Healthcare Company, Inc. (0001520697) (Subject)

    11/8/24 10:52:39 AM ET
    $ACHC
    Medical Specialities
    Health Care

    $ACHC
    $AFTR
    Financials

    Live finance-specific insights

    View All

    Acadia Healthcare Announces Date for First Quarter 2026 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its first quarter 2026 results on Wednesday, April 29, 2026, after the close of the market. Acadia will also conduct a conference call with institutional investors and analysts on Thursday, April 30, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States. As of December 31, 2025, Acadia operated a network of 277 behavioral healthcare fa

    4/8/26 10:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Fourth Quarter and 2025 Results

    Company Provides First Quarter and Full Year 2026 Guidance Debbie Osteen Joins Acadia as Chief Executive Officer Acadia Healthcare Company, Inc. ("Acadia" or the "Company") (NASDAQ:ACHC) today announced financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 Results Revenue totaled $821.5 million, a 6.1% increase compared with the fourth quarter of 2024, supporting full-year revenue results above the Company's previously issued guidance range Same facility revenue increased 4.4% compared with the fourth quarter of 2024, including an increase in patient days of 3.1% and an increase in revenue per patient day of 1.3% Net loss attributable

    2/25/26 7:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care

    Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release

    Acadia Healthcare Company, Inc. (NASDAQ:ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the "Investors" section of the website. The webcast of the conference call will be available for 30 days. About Acadia Healthcare Acadia is a leading provider of behavioral healthcare services across the United States (the "U.S."). As of September 30, 2025, Acadia operated a network of

    2/4/26 10:00:00 AM ET
    $ACHC
    Medical Specialities
    Health Care